Format

Send to

Choose Destination
BMC Nephrol. 2017 Jun 14;18(1):193. doi: 10.1186/s12882-017-0606-6.

End-stage kidney disease in patient with epidermolysis bullosa - what are the treatment options? - case report.

Author information

1
Department of Nephrology, Transplantation and Internal Medicine, Pomeranian Medical University, Al. Powstańców Wielkopolskich 72, 70-111, Szczecin, Poland.
2
Department of Nephrology, Transplantation and Internal Medicine, Pomeranian Medical University, Al. Powstańców Wielkopolskich 72, 70-111, Szczecin, Poland. macd@mp.pl.

Abstract

BACKGROUND:

Epidermolysis bullosa is a group of diseases caused by mutations in genes for proteins responsible for cells' anchorage at the dermo-epidermal junction. Their common feature are dysfunctional or even absent connections between cells. The typical clinical sign is the formation of blisters, with possible excessive scarring, in response to minimal skin irritation. End stage renal disease may be one of the comorbidities in patients with epidermolysis bullosa. The implementation of renal replacement therapy may be very difficult in this population. This is mainly due to problems in obtaining the proper dialysis access. The choice of appropriate method may be crucial for patient's survival.

CASE PRESENTATION:

We present a case of 29-year-old woman with Epidermolysis bullosa caused by laminin 5 gene mutation. The patient suffered from additional conditions: blindness, complete bilateral sensorineural deafness and oesophageal stenosis. When end stage renal disease was diagnosed, the problem of renal replacement therapy had to be faced. There have been few reports concerning ESRD in this specific group of patients in the available literature. In most of them the prognosis was very poor. Nevertheless, we were very determined to overcome all the difficulties. Special procedures and cooperation with the patient's family allowed us to consider kidney transplantation as a treatment option.

CONCLUSION:

There should be no limitations in renal replacement therapy in patients with epidermolysis bullosa. Haemodialysis, peritoneal dialysis and kidney transplantation are all possible treatment options. Nevertheless, either method requires special procedures.

KEYWORDS:

Epidermolysis bullosa; Haemodialysis; Kidney transplantation; Peritoneal dialysis

PMID:
28615054
PMCID:
PMC5471905
DOI:
10.1186/s12882-017-0606-6
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center